Study reveals how patients' smoking history changes evolution of lung cancer

by Walter and Eliza Hall InstituteThis immunofluorescence image shows the presence of a specific subset of T cells (tissue-resident memory T cells, TRM) in the lung of smoker patients. The TRM ce

Updated on: February 20,2024

Study reveals how patients' smoking history changes evolution of lung cancer

by Walter and Eliza Hall InstituteThis immunofluorescence image shows the presence of a specific subset of T cells (tissue-resident memory T cells, TRM) in the lung of smoker patients. The TRM ce

Updated on:February 20,2024

New study supports annual breast cancer screening for women over 40

by Asher Jones and Cynthia Patton,University of Pittsburgh Schools of the Health SciencesCredit: Pixabay/CC0 Public DomainWomen diagnosed with breast cancer who had regular screening mammograms

Updated on: September 07,2024

New study supports annual breast cancer screening for women over 40

by Asher Jones and Cynthia Patton,University of Pittsburgh Schools of the Health SciencesCredit: Pixabay/CC0 Public DomainWomen diagnosed with breast cancer who had regular screening mammograms

Updated on:September 07,2024

Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

by Justin Jackson , Medical XpressMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaA one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) ther

Updated on: January 02,2024

Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

by Justin Jackson , Medical XpressMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaA one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) ther

Updated on:January 02,2024

Anticancer vaccines gain new lease of life with personalisation techniques

by European Society for Medical OncologyCredit: CC0 Public DomainAnticancer vaccines have gained a new lease of life with techniques to personalise them to individual patients. Cutting edge devel

Updated on: March 01,2024

Anticancer vaccines gain new lease of life with personalisation techniques

by European Society for Medical OncologyCredit: CC0 Public DomainAnticancer vaccines have gained a new lease of life with techniques to personalise them to individual patients. Cutting edge devel

Updated on:March 01,2024

Direct oral anticoagulant therapy found to be feasible for cancer patients

by Lori SolomonDirect oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients, according to a

Updated on: February 18,2024

Direct oral anticoagulant therapy found to be feasible for cancer patients

by Lori SolomonDirect oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients, according to a

Updated on:February 18,2024

New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

byHelmholtz Association of German Research CentresmCSF1R CART do not cause toxicity in mice. Credit:Nature Biotechnology(2023). https://doi.org/10.1038/s41587-023-01684-0Unlike other

Updated on: January 07,2024

New targets for CAR-T cell therapy against acute myeloid leukemia through AI-assisted analysis

byHelmholtz Association of German Research CentresmCSF1R CART do not cause toxicity in mice. Credit:Nature Biotechnology(2023). https://doi.org/10.1038/s41587-023-01684-0Unlike other

Updated on:January 07,2024

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Updated on: November 09,2024

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Updated on:November 09,2024

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d

Updated on: February 18,2024

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d

Updated on:February 18,2024

Immune cells assemble to boost the effects of chemotherapy in pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA new study from Queen Mary University of London has

Updated on: May 28,2024

Immune cells assemble to boost the effects of chemotherapy in pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA new study from Queen Mary University of London has

Updated on:May 28,2024

Women may not recognize non-lump symptoms of breast cancer

by Lori SolomonFewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State Uni

Updated on: March 09,2024

Women may not recognize non-lump symptoms of breast cancer

by Lori SolomonFewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State Uni

Updated on:March 09,2024

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Updated on: January 11,2024

Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel

Updated on:January 11,2024

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus

Updated on: July 17,2024

New biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

by Germans Trias i Pujol Research InstituteGraphical abstract. Credit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.116857Colorectal cancer is the second leading caus

Updated on:July 17,2024